Table 4 delineates the critical knowledge gaps and articulates specific, actionable research priorities essential for constructing a strategic roadmap to inform and guide future investigations in this domain
Losing it can: Lower your resting metabolic rate Make long-term weight maintenance harder Increase fatigue and weakness Reduce strength and mobility This can create a cycle where weight becomes even harder to manage over time
There is no single published list of FDA-approved peptides, but the category of formally approved peptide-based drugs includes GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound), insulin analogues, leuprolide, vasopressin analogues, oxytocin, and several others used in endocrinology and oncology
Scientists dont have the answer to that one, either